Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Asset Writedowns and Impairment came in at $1.3 million in Q1 2026, down 24.68% year-on-year from $1.7 million in Q1 2025, and up 1115.62% quarter-over-quarter from -$128000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 24.68% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 30.03% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, up 53.66% from the prior year.
- Asset Writedowns and Impairment grew to $1.3 million in Q1 2026 per ESTA's latest filing, from -$128000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q1 2025 and bottomed at -$1.3 million in Q2 2022.
- The 5-year median for Asset Writedowns and Impairment is $282000.0 (2023), against an average of $498117.6.
- Biggest YoY gain for Asset Writedowns and Impairment was 23483.33% in 2022; the steepest drop was 1185.34% in 2022.
- Year by year, Asset Writedowns and Impairment stood at $90000.0 in 2022, then soared by 85.56% to $167000.0 in 2023, then soared by 456.29% to $929000.0 in 2024, then sank by 113.78% to -$128000.0 in 2025, then soared by 1115.62% to $1.3 million in 2026.
- Per Business Quant, the three latest ESTA Asset Writedowns and Impairment figures stand at $1.3 million (Q1 2026), -$128000.0 (Q4 2025), and $810000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -128,000.00 |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 929,000.00 |
| Dec 31, 2024 | 929,000.00 |
| Sep 30, 2024 | 440,000.00 |
| Sep 30, 2024 | 440,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Dec 31, 2023 | 167,000.00 |